Search Results 281-290 of 16802 for ESCITALOPRAM+OXALATE
ID-LV305 is a novel immunotherapy agent designed to target dendritic cells and stimulate the body's immune system to fight the spread and growth of cancer for ...
Serum monoclonal protein >= 1.0 g/dL · > 200 mg of monoclonal protein in the urine on 24 hour electrophoresis · Serum immunoglobulin free light chain >= 10 mg/dL ...
Dasatinib is in a class of medications called tyrosine kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to ...
The purpose of this study is to identify correlates of healthcare-seeking behavior in patients with ACS and CHF and its association with psychosocial and health ...
The purpose of this study is to determine whether patients with ADPKD present with abnormal levels of fumarate that correlates with disease severity and this ...
However, the dose is usually not more than 300 milligrams (mg) of aliskiren, 10 mg of amlodipine, and 25 mg of hydrochlorothiazide once a day. Children—Use ...
About this study. The purposes of this study are to explore the association between female sex, reproductive history and clinical phenotypic variability in ...
This study aims to identify candidate High Grade Serous Cancer (HGSC) early detection and chemotherapy treatment response biomarkers. For the purpose of this ...
Inclusion criteria: Patients post bilateral thyroid bed surgery (cancer, Graves' disease, multinodular goiter); Symptomatic hypocalcemia; Total calcium < 8 ...
Determine the preexisting and therapy-emergent germline and somatic variants associated with an increased risk of clonal and non-clonal cytopenia following CAR- ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!